The US Food and Drug Administration (FDA) has granted 510(k) clearance for Bioventus’ StimRouter Neuromodulation System.
The next-generation pain treatment device is designed to treat chronic pain of peripheral nerve origin, excluding craniofacial pain.
StimRouter is a minimally invasive device, which comprises a thin, implanted lead with a conductive electrode, StimRouter Plus Mobile Application and external electric field conductor (E-EFC).
It transmits the electrical signals transcutaneously from the E-EFC and guides to the targeted nerve by the implanted lead.
